Literature DB >> 8319587

The biological roles of the third component of complement in osteoclast formation.

T Sato1, E Abe, C H Jin, M H Hong, T Katagiri, T Kinoshita, N Amizuka, H Ozawa, T Suda.   

Abstract

We previously reported that 1 alpha,25-dihydroxyvitamin D3 [1 alpha,25-(OH)2D3] tissue-specifically stimulated the production of the third component of complement (C3) in bone in vitro and in vivo. In the present study, we examined the possible roles of C3 in bone using bone marrow cultures with antibodies against C3 and C3 receptors (Mac 1, 8C12, and 7G6) and the purified mouse C3 protein. The C3 protein produced preferentially by stromal cells in response to 1 alpha,25-(OH)2D3 was distributed in macrophage-like mononuclear cells and small cells with few nuclei. Adding anti-C3 antibody together with 1 alpha,25-(OH)2D3 to bone marrow cultures greatly inhibited not only the appearance of tartrate-resistant acid phosphatase (TRAP)-positive mononuclear and multinucleated cells, but also the growth of macrophage-like mononuclear cells and stromal cells. The inhibitory effect of anti-C3 antibody on osteoclast-like cell formation was most prominent when it was added between days 2-4 of the 6-day culture period, which corresponded to the late proliferative phase and the early differentiation phase of osteoclast development. Adding anti-C3 receptor antibodies also inhibited osteoclast-like cell formation induced by 1 alpha,25-(OH)2D3. When C3 receptors were detected by the binding of C3-coated sheep red blood cells or immunostaining, the localization of C3 receptor-positive cells coincided exactly with that of C3 protein-positive cells. C3 receptors were expressed mainly in macrophage-like mononuclear cells, TRAP-positive mononuclear cells, and TRAP-positive small cells with few nuclei. TRAP-positive large cells with many nuclei were totally negative for C3 receptors. When macrophage-colony-stimulating factor (M-CSF), the purified C3 protein, and 1 alpha,25-(OH)2D3 were added to bone marrow methylcellulose cultures, separately or in combination, M-CSF-dependent colony formation was strikingly inhibited by 1 alpha,25-(OH)2D3, but the inhibition was prevented by simultaneously adding C3. These results provide additional evidence that osteoclast progenitors are indeed cells of the monocyte-macrophage lineage. It is likely that the C3 produced by stromal cells in response to 1 alpha,25-(OH)2D3 is somehow involved in osteoclast development by potentiating M-CSF-dependent proliferation of bone marrow cells and induction of osteoclast differentiation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8319587     DOI: 10.1210/endo.133.1.8319587

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  17 in total

1.  Reduced bone loss in a murine model of postmenopausal osteoporosis lacking complement component 3.

Authors:  Danielle L MacKay; Thomas J Kean; Kristina G Bernardi; Heather S Haeberle; Catherine G Ambrose; Feng Lin; James E Dennis
Journal:  J Orthop Res       Date:  2017-07-25       Impact factor: 3.494

2.  A novel composition for the culture of human adipose stem cells which includes complement C3.

Authors:  Sangeetha Hareendran; Solomon Sathishkumar; Salar Abbas; Alastair M Mackay; Prithi Rajan
Journal:  Cytotechnology       Date:  2010-09-11       Impact factor: 2.058

3.  Efficient osteoclast differentiation requires local complement activation.

Authors:  Zhidan Tu; Hong Bu; James E Dennis; Feng Lin
Journal:  Blood       Date:  2010-08-13       Impact factor: 22.113

4.  The anaphylatoxin receptor C5aR is present during fracture healing in rats and mediates osteoblast migration in vitro.

Authors:  Anita Ignatius; Christian Ehrnthaller; Rolf E Brenner; Ludwika Kreja; Philipp Schoengraf; Patricia Lisson; Robert Blakytny; Stefan Recknagel; Lutz Claes; Florian Gebhard; John D Lambris; Markus Huber-Lang
Journal:  J Trauma       Date:  2011-10

5.  Complement C3a and C5a modulate osteoclast formation and inflammatory response of osteoblasts in synergism with IL-1β.

Authors:  Anita Ignatius; Philipp Schoengraf; Ludwika Kreja; Astrid Liedert; Stefan Recknagel; Sebastian Kandert; Rolf E Brenner; Marion Schneider; John D Lambris; Markus Huber-Lang
Journal:  J Cell Biochem       Date:  2011-09       Impact factor: 4.429

Review 6.  The complement cascade as a mediator of tissue growth and regeneration.

Authors:  Martin J Rutkowski; Michael E Sughrue; Ari J Kane; Brian J Ahn; Shanna Fang; Andrew T Parsa
Journal:  Inflamm Res       Date:  2010-06-02       Impact factor: 4.575

7.  Human blood-mobilized hematopoietic precursors differentiate into osteoclasts in the absence of stromal cells.

Authors:  A Matayoshi; C Brown; J F DiPersio; J Haug; Y Abu-Amer; H Liapis; R Kuestner; R Pacifici
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

Review 8.  Complement-triggered pathways orchestrate regenerative responses throughout phylogenesis.

Authors:  Dimitrios C Mastellos; Robert A Deangelis; John D Lambris
Journal:  Semin Immunol       Date:  2013-05-17       Impact factor: 11.130

Review 9.  Complement: structure, functions, evolution, and viral molecular mimicry.

Authors:  Dimitrios Mastellos; Dimitrios Morikis; Stuart N Isaacs; M Claire Holland; Cristoph W Strey; John D Lambris
Journal:  Immunol Res       Date:  2003       Impact factor: 4.505

10.  Abrogated RANKL expression in properdin-deficient mice is associated with better outcome from collagen-antibody-induced arthritis.

Authors:  Petya Dimitrova; Nina Ivanovska; Lyudmila Belenska; Viktoriya Milanova; Wilhelm Schwaeble; Cordula Stover
Journal:  Arthritis Res Ther       Date:  2012-07-25       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.